Records containing: Neurofibromatosis 2
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-13Open-label, Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
-
CLINICAL_TRIALS study record update · 2025-12-24Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing
-
CLINICAL_TRIALS study record update · 2025-12-18Prospective, Randomized, Placebo-Controlled Phase II Trial of Aspirin for Vestibular Schwannomas
-
CLINICAL_TRIALS study record update · 2025-04-22Phase 2 Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors
-
CLINICAL_TRIALS study record update · 2024-03-2089Zr-Bevacizumab PET/CT Imaging of Vestibular Schwannomas for the Prediction of Bevacizumab Treatment Effect in Patients With Symptomatic Neurofibromatosis Type 2
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-08-30Neurofibromatosis (NF) Registry Portal Funded by Children's Tumor Foundation
-
CLINICAL_TRIALS study record update · 2023-03-16Vestibular Precision: Physiology & Pathophysiology
-
CLINICAL_TRIALS study record update · 2020-12-22A Single Arm Phase 2 Study of the Dual mTORC1/mTORC2 Inhibitor AZD2014 Provided on an Intermittent Schedule for Neurofibromatosis 2 Patients With Progressive or Symptomatic Meningiomas
-
CLINICAL_TRIALS study record update · 2019-04-12A Phase 2 Study to Assess the Efficacy, Safety, and Pharmacodynamic Activity of PTC299 in Patients With Neurofibromatosis Type 2
-
CLINICAL_TRIALS study record update · 2019-03-28Multicentre Prospective Observational Study: Resentment of Mucocutaneous Manifestations and the Value of Dermatological Examination in the Early Detection of Type 2 Neurofibromatosis in Children Under 15 Years of Age
-
CLINICAL_TRIALS study record update · 2018-11-26Exploration and Estimation of Intratumoral Concentration and Activity of Lapatinib in Vivo in Vestibular Schwannomas
-
CLINICAL_TRIALS study record update · 2018-08-17Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype
-
CLINICAL_TRIALS study record update · 2018-08-06A Study Investigating the Inter- and Intra- Rater Reliability of Functional Outcome Measures in Neurofibromatosis 2
-
CLINICAL_TRIALS study record update · 2017-05-23A Single Arm, Single Center, Phase II Trial of RAD001 as Monotherapy in the Treatment of Neurofibromatosis Type 2 - Related Vestibular Schwannoma
-
CLINICAL_TRIALS study record update · 2016-06-23Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype
-
CLINICAL_TRIALS study record update · 2016-03-22Phase II Study of Lapatinib in Children and Adults With Neurofibromatosis Type 2(NF2) and NF2-related Tumors
-
CLINICAL_TRIALS study record update · 2015-03-25ClinicalTrials.gov study NCT00004437
-
CLINICAL_TRIALS study record update · 2015-03-25Penetrating Auditory Brainstem Implant for Neurofibromatosis 2